Insomnia drug approved in Europe
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as1
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as1
Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson\'s disease,1
A study with the participation of millions of people has concluded that antidepressants do not improve the long-term quality of life of patients. Dr1
According to the latest data from the Ministry of Health, alcohol and tobacco are still the most common drugs taken legally in Spain, followed by the1
Interview with Dr. Mª Josep Martí, neurologist and head of the IDIBAPS Parkinson’s Disease and other Neurodegenerative Movement Disorders research gr1
On 24 February, the Russian President Vladimir Putin ordered an attack on the Donbas region of Ukraine. It was the start of a war with incalculable c1
The Hospital Clínic de Barcelona is consolidating its transorbital surgery programme for patients with skull base tumours. This surgery is led by the1
The Joan Rodés-Josep Baselga Advanced Research Contracts in Oncology and Neurodegenerative Diseases, awarded by the BBVA Foundation and Hospital Clín1
The study, led by researchers from Hospital Clínic-IDIBAPS, will be a paradigm shift in the treatment of the disease worldwide
A new international study, in which Hospital Clínic-IDIBAPS researchers took part, shows that people with schizophrenia who are not eligible for clin1